Published in Medicine and Law Weekly, December 9th, 2005
The new codes are effective for services performed on or after January 1, 2006.
"We are delighted that CMS recognizes the value that rechargeable neurostimulators such as the Precision SCS System offer to Medicare patients," said Jeff Greiner, head of Boston Scientific's Neuromodulation Group. "This favorable decision will help...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.